Access DX Laboratory LLC

Access DX Laboratory LLC was paid $4.26M by Medicaid between Sep 2018 and Oct 2024, across 63 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 88% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#29 of 436

Median peer was paid$17K

This provider vs. median247×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	299	$0.00
2019	5,003	$3K
2020	42,446	$1.10M
2021	104,246	$1.91M
2022	45,433	$1.21M
2023	5,116	$27K
2024incomplete	833	$347.46

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	88%	120,914	50,385	$3.75M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	68,455	31,595	$478K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	198	187	$9K
81225		<1%	432	416	$3K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	58	49	$3K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	605	502	$2K
81227		<1%	456	440	$2K
87640		<1%	703	617	$1K
87653		<1%	619	544	$1K
81418		<1%	530	514	$1K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	619	544	$1K
81241		<1%	443	427	$1K

51 more codes

81240		<1%	443	$981.08
81355		<1%	456	$929.03
87581		<1%	398	$867.65
87541		<1%	395	$866.92
81291		<1%	457	$844.25
87631		<1%	241	$685.91
81401		<1%	420	$674.04
81335		<1%	440	$549.66
87486		<1%	294	$502.79
81226		<1%	456	$468.95
81230		<1%	456	$410.82
81231		<1%	444	$410.82
81328		<1%	444	$410.82
87561		<1%	169	$362.74
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	185	$362.74
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	564	$267.17
80053	Comprehensive metabolic panel	<1%	186	$237.60
80048	Basic metabolic panel (calcium, ionized)	<1%	294	$178.50
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	208	$113.60
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	25	$31.32
87500		<1%	172	$29.97
81001		<1%	145	$27.80
83036	Hemoglobin; glycosylated (A1C)	<1%	24	$27.30
83735		<1%	44	$11.26
81201		0%	72	$0.00
81295		0%	72	$0.00
81400		0%	12	$0.00
81298		0%	72	$0.00
0031U		0%	157	$0.00
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	0%	42	$0.00
81162		0%	57	$0.00
87529		0%	42	$0.00
87496		0%	26	$0.00
87498		0%	26	$0.00
87532		0%	26	$0.00
81435		0%	24	$0.00
81408		0%	77	$0.00
87641		0%	174	$0.00
81404		0%	159	$0.00
81317		0%	97	$0.00
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	0%	25	$0.00
81405		0%	129	$0.00
81403		0%	16	$0.00
87563		0%	96	$0.00
87481		0%	153	$0.00
81292		0%	72	$0.00
87634		0%	25	$0.00
0032U		0%	134	$0.00
81406		0%	112	$0.00
81321		0%	72	$0.00
81211		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCIPRIANI, BRYON (AUTHORIZED OFFICIAL)